^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

fluoxetine

i
Other names: LY-110140, LY 110140
Company:
Generic mfg.
Drug class:
Selective serotonin reuptake inhibitor
4d
Acupuncture as a modulator of microglial polarization and pyroptosis in depression: evidence from a chronic unpredictable mild stress rat model. (PubMed, Metab Brain Dis)
Acupuncture alleviates depression-like behaviors in CUMS-induced rats by modulating microglial polarization and inhibiting neuroinflammation-mediated pyroptosis. Our findings provide further evidence supporting acupuncture as a viable strategy for depression treatment.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • IL1B (Interleukin 1, beta) • IL4 (Interleukin 4) • MRC1 (Mannose Receptor C-Type 1) • NLRP3 (NLR Family Pyrin Domain Containing 3) • CASP1 (Caspase 1)
|
fluoxetine
7d
Hypersensitization of peripheral immune cells from major depressive disorder patients is mildly attenuated by fluoxetine in vitro. (PubMed, Prog Neuropsychopharmacol Biol Psychiatry)
In summary, fluoxetine has highly significant immunoregulatory effects in patients with MDD and not in controls. Unfortunately, these effects only partly attenuate the immune sensitization in MDD.
Preclinical • Journal
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CCL27 (C-C Motif Chemokine Ligand 27)
|
fluoxetine
12d
Xianglian Pills ameliorate ulcerative colitis combined with depression in mice via histone demethylation (PubMed, Zhongguo Zhong Yao Za Zhi)
Fifty male C57BL/6 mice were randomized into control, model, XLP(2.7, 5.4 mg·g~(-1)), and 5-aminosalicylic acid+fluoxetine groups...Furthermore, XLP lowered the levels of TNF-α, IL-1β, IL-6, and IL-23, down-regulated the transcript levels of IL-6 and IL-23α and the protein level of H3K4me3 while up-regulating the protein level of KDM5B in the cerebral cortical area and the colon tissue, and increased the binding of KDM5B to the IL-6 and IL-23α promoters. XLP may affect H3K4me3 demethylation through KDM5B to reduce the production of inflammatory factors and alleviate the inflammatory response, thus ameliorating UC combined with depression.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL23A (Interleukin 23 Subunit Alpha) • IL1B (Interleukin 1, beta) • KDM5B (Lysine Demethylase 5B)
|
fluoxetine
1m
Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer. (PubMed, Cell Metab)
Attenuating peripheral serotonin using fluoxetine-a selective serotonin reuptake inhibitor (SSRI) antidepressant-ablates TAM-derived EV delivering of inositol metabolic enzymes and sensitizes tumors to cisplatin/PARP inhibitor (PARPi). Our study unveils a systemic serotonin-primed metabolic crosstalk within the tumor microenvironment that potentiates chemoresistance, revealing targetable HR repair regulation beyond cancer-cell-autonomous mechanisms.
Journal
|
MRE11A (MRE11 homolog, double strand break repair nuclease)
|
cisplatin • fluoxetine
2ms
Effects of Saikosaponin A on Post-Traumatic Stress Disorder-Like Behaviors, Hippocampal Monoaminergic Neurotransmission, and the NF-κB Inflammatory Pathway in a Rat model. (PubMed, Behav Brain Res)
Rats were randomly assigned to control, model, SSa treatment, and fluoxetine-positive control groups...Mechanistically, SSa restored depleted hippocampal 5-HT levels, reduced pro-inflammatory cytokines expression (TNF-α, IL-6, IL-1β), and suppressed NF-κB p65 activation. These findings demonstrate that SSa exerts therapeutic effect against PTSD-like behavior through dual mechanisms: restoration of hippocampal serotonergic neurotransmission and suppression of NF- κB- mediated neuroinflammation, positioning SSa as a promising candidate for PTSD treatment.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
fluoxetine
2ms
Dapagliflozin in Depression (clinicaltrials.gov)
P1/2, N=60, Recruiting, Tanta University | Not yet recruiting --> Recruiting
Enrollment open
|
fluoxetine
2ms
The Friendship Bench Plus Trial (clinicaltrials.gov)
P=N/A, N=296, Recruiting, University of Bern | Active, not recruiting --> Recruiting
Enrollment open
|
fluoxetine
2ms
Dapagliflozin in Depression (clinicaltrials.gov)
P1/2, N=60, Not yet recruiting, Tanta University
New P1/2 trial
|
fluoxetine
2ms
Unveiling the enzymatic activity of a dimeric LDH isoform and its implications for allosteric inhibition strategies. (PubMed, Protein Sci)
Furthermore, reported LDH allosteric inhibitors, including cGmC9 and fluoxetine, preferentially inhibited LDHBtr compared to the native LDHB, by preventing tetramer formation. Overall, this work highlights the central role of tetramerization in regulating LDH activity, and the therapeutic potential of targeting this process. It also establishes LDHBtr as a valuable tool for screening tetramerization disruptors, paving the way for next-generation LDH inhibitors to target cancer metabolism.
Journal
|
LDHB (L-lactate dehydrogenase B chain)
|
fluoxetine
3ms
Serotonin promotes aggressive features in breast cancer cells by modulating proliferation and migration, hormone receptors and HER2 expression. (PubMed, Mol Cell Endocrinol)
Despite these phenotypic changes, acute 5-HT treatment does not impair the effectiveness of tamoxifen in vitro. In vivo, administration of fluoxetine, a selective serotonin reuptake inhibitor, accelerates tumor growth and increases malignancy in a murine model. These findings underscore the ability of 5-HT to reprogram hormone receptors expression profiles and to promote a more aggressive cancer phenotype.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 expression
|
tamoxifen • fluoxetine
3ms
Antidepressant-like and memory-enhancing effects of 2-phenyl-3-(phenylselanyl)benzofuran on a lipopolysaccharide-induced depression model in male mice: behavioral, biochemical, and molecular insights. (PubMed, Brain Res)
SeBZF1 (50 mg/kg, intragastrically) or fluoxetine (20 mg/kg, intraperitoneally, i.p, positive control) was administered 30 min before LPS (0.83 mg/kg, i.p.), and behavior assessed 24 h later...SeBZF1 also downregulated cortical IL-4 expression. Overall, SeBZF1 demonstrated antidepressant-like, antioxidant, and anti-inflammatory effects, supporting its potential as a candidate for depression associated with neuroinflammation.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • IL4 (Interleukin 4)
|
fluoxetine
3ms
New trial
|
fluoxetine